Clinical trial finds no benefit from aspirin in preventing colorectal cancer recurrence
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Business Wire3d
New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year’s Resolutions
A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests ...
Multiple Sclerosis News Today4d
Bayer’s MRI contrast agent effective with 60% less gadolinium: Data
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
MedPage Today4d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...